Balchem Corp
BCPC
Classifica tra le azioni
#3252
Balchem Corporation develops, manufactures, and distributes specialty... Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Prezzo delle azioni
$170.40
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$5.43B
Variazione (1 giorno)
-0.19%
Variazione (1 anno)
13.02%
Paese
US
Scambia Balchem Corp (BCPC)
Categoria
Basic Materials
Rapporto P/E per Balchem Corp (BCPC)
Rapporto P/E al October 2026 TTM: 33.29
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Balchem Corp, il rapporto P/E attuale (TTM) è 33.29. Alla fine del 2023, il rapporto P/E era 44.00.
Storico del rapporto P/E per Balchem Corp da 2000 a 2026
Rapporto P/E alla fine di ogni anno
| Anno | Rapporto P/E | Cambia |
|---|---|---|
| 2026 (TTM) | 33.29 | -18.84% |
| 2024 | 41.02 | -6.77% |
| 2023 | 44.00 | 18.58% |
| 2022 | 37.11 | -34.34% |
| 2021 | 56.52 | 29.00% |
| 2020 | 43.81 | 6.87% |
| 2019 | 40.99 | 27.45% |
| 2018 | 32.16 | 12.26% |
| 2017 | 28.65 | -39.82% |
| 2016 | 47.62 | 50.11% |
| 2015 | 31.72 | -18.48% |
| 2014 | 38.91 | 0.41% |
| 2013 | 38.75 | 44.40% |
| 2012 | 26.84 | -10.19% |
| 2011 | 29.88 | 5.18% |
| 2010 | 28.41 | 17.98% |
| 2009 | 24.08 | 2.48% |
| 2008 | 23.50 | -4.45% |
| 2007 | 24.59 | 0.59% |
| 2006 | 24.45 | 16.30% |
| 2005 | 21.02 | -3.15% |
| 2004 | 21.71 | 11.49% |
| 2003 | 19.47 | 25.00% |
| 2002 | 15.58 | -19.80% |
| 2001 | 19.42 | 17.14% |
| 2000 | 16.58 | 0.00% |
Rapporto P/E per aziende simili o concorrenti
| Azienda | P/E Ratio | Differenza del P/E Ratio | Il paese |
|---|---|---|---|
| 31.66 | -4.89% |
GB
|
|
| - | - |
FR
|
|
| 29.64 | -10.98% |
US
|
|
| 38.37 | 15.26% |
US
|
|
| -1.41K | -4,324.29% |
US
|
Come leggere un P/E ratio?
Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.
Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.
Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.